Great Valley Advisor Group, Inc. Novavax Inc Transaction History

Great Valley Advisor Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$36.28 - $75.29 $204,038 - $423,430	-5,624 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$69.73 - $142.9 $146,014 - $299,232	2,094 Added 59.32%	5,624 $417,000
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $181,386 - $293,823	1,348 Added 61.78%	3,530 $509,000
Q3 2021 Oct 14, 2021	BUY	$177.8 - $270.58 $38,049 - $57,904	214 Added 10.87%	2,182 $453,000
Q2 2021 Jul 27, 2021	BUY	$121.0 - $257.67 $12,463 - $26,540	103 Added 5.52%	1,968 $416,000

Q1 2021 Apr 20, 2021	SELL	$112.98 - $319.93 $198,279 - $561,477	-1,755 Reduced 48.48%	1,865 $338,000
Q4 2020 Jan 29, 2021	SELL	$78.74 - $139.5 $1,811 - $3,208	-23 Reduced 0.63%	3,620 $404,000
Q3 2020 Oct 21, 2020	BUY	$79.44 - $178.51 $289,399 - $650,311	3,643 New	3,643 $394,000

241

76.1M

5.06M

7.19M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $990M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.